Welcome to LookChem.com Sign In|Join Free

CAS

  • or

871571-29-8

3-Methyl-4-(trifluoromethyl)benzoic acid is an organic compound characterized by the presence of a methyl group at the 3rd position and a trifluoromethyl group at the 4th position on a benzene ring, with a carboxylic acid functional group. It serves as a key intermediate in the synthesis of various pharmaceutical compounds.

871571-29-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 871571-29-8 Structure

  • Basic information

    1. Product Name: 3-Methyl-4-(trifluoromethyl)benzoic acid
    2. Synonyms: 3-Methyl-4-(trifluoromethyl)benzoic acid
    3. CAS NO:871571-29-8
    4. Molecular Formula: C9H7F3O2
    5. Molecular Weight: 204.1458896
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 871571-29-8.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-Methyl-4-(trifluoromethyl)benzoic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-Methyl-4-(trifluoromethyl)benzoic acid(871571-29-8)
    11. EPA Substance Registry System: 3-Methyl-4-(trifluoromethyl)benzoic acid(871571-29-8)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 871571-29-8(Hazardous Substances Data)

871571-29-8 Usage

Uses

Used in Pharmaceutical Industry:
3-Methyl-4-(trifluoromethyl)benzoic acid is used as a chemical intermediate for the preparation of pyrazolopyrimidine derivatives and similar compounds. These compounds are valuable as they act as metabotropic glutamate receptor antagonists, playing a significant role in the development of drugs targeting neurological disorders and conditions related to glutamate receptor dysfunction.

Check Digit Verification of cas no

The CAS Registry Mumber 871571-29-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,5,7 and 1 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 871571-29:
(8*8)+(7*7)+(6*1)+(5*5)+(4*7)+(3*1)+(2*2)+(1*9)=188
188 % 10 = 8
So 871571-29-8 is a valid CAS Registry Number.

871571-29-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-methyl-4-(trifluoromethyl)benzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:871571-29-8 SDS

871571-29-8Relevant articles and documents

Novel compounds as metabotropic glutamate receptor antagonists

-

Page/Page column 11, (2008/06/13)

The present invention relates to compounds of formula (I) wherein A, E G, J, L, M, R1, R2, and R3 are as defined in the specification and claims. The invention also relates to pharmaceutical compositions containing such compounds and methods for preparing the compounds and compositions. The compounds are metabotropic glutamate receptor antagonists and are useful for the treatment of a variety of CNS disorders.

Pyrrazolo-pyrimidine derivatives

-

Page/Page column 11, (2008/06/13)

The present invention relates to pyrrazolo-pyrimidine derivatives of formula (I): wherein R1 to R4 and A are as defined in the specification, a process for the manufacture thereof, their use for treating or preventing metabotropic glutamate receptors mediated disorders, their use for the preparation of medicaments for treating such disorders and pharmaceutical compositions containing said derivatives.

Acetylenyl-pyrazolo-pyrimidine derivatives

-

Page/Page column 23, (2008/06/13)

The present invention relates to compounds of formula (I): wherein R1 to R3, A, M, L, E, G, and J are as defined in the description and claims. The invention also relates to a process for the manufacture of such compounds, pharmaceutical compositions containing them, and methods for treating CNS disorders.

PYRRAZOLO-PYRIMIDINE DERIVATIVES

-

Page/Page column 27, (2010/02/15)

The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5 and p are as defined in the description and claims as well as to pharmaceutically acceptable salts thereof per se and as ph

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 871571-29-8